References
1. Vowles KE, McEntee ML, Julnes PS, et al. Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain 2015;156:5692013;576.
3. Dowell D, Haegerich T, Chou R. No shortcuts to safer opioid prescribing. N Engl J Med 2019;380:22852013;2287.
5. Centers for Disease Control and Prevention, National Center for Injury Prevention and Control. Opioid prescribing resources. https://www.cdc.gov/opioids/healthcareprofessionals/prescribing/index.html. Accessed November 28, 2023.
8. Ahmed F. US Advisory Committee on Immunization Practices (ACIP): evidence-based recommendations–GRADE.
https://www.cdc.gov/vaccines/. Accessed October 31, 2023.
9. Skelly AC, Chou R, Dettori JR, et al. Noninvasive Nonpharmacological Treatment for Chronic Pain: A Systematic Review Update. Report no. 20- EHC009. Rockville, MD: Agency for Healthcare Research and Quality; 2020.
10. Chou R, Wagner J, Ahmed A, et al. Treatments for Acute Pain: A Systematic Review. Comparative Effectiveness Review no. 240. Rockville, MD: Agency for Healthcare Research and Quality; 2020.
11. Bannuru RR, Osani MC, Vaysbrot EE, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage 2019;27:15782013;1589.
12. Loder E, Weizenbaum E, Frishberg B, et al. Choosing wisely in headache medicine: the American Headache Society’s list of five things physicians and patients should question. Headache 2013;53:16512013;1659.
13. Gaskell H, Moore RA, Derry S, et al. Oxycodone for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev 2014;6:CD010692.
14. Chou R, Hartung D, Turner J, et al. Opioid Treatments for Chronic Pain. Comparative Effectiveness Review no. 229. Rockville, MD: Agency for Healthcare Research and Quality; 2020.
15. Miller M, Barber CW, Leatherman S, et al. Prescription opioid duration of action and the risk of unintentional overdose among patients receiving opioid therapy. JAMA Intern Med 2015;175:6082013;615.
16. Dunn KM, Saunders KW, Rutter CM, et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med 2010;152:85–92.
17. Gomes T, Mamdani MM, Dhalla IA, et al. Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med 2011;171: 6862013;691.
18. Hill MV, McMahon ML, Stucke RS, et al. Wide variation and excessive dosage of opioid prescriptions for common general surgical procedures. Ann Surg 2017;265:709–714.
19. Hill MV, Stucke RS, McMahon ML, et al. An educational intervention decreases opioid prescribing after general surgical operations. Ann Surg 2018;267:468–472.
20. Mallama CA, Greene C, Alexandridis AA, et al. Patient-reported opioid analgesic use after discharge from surgical procedures: a systematic review. Pain Med 2022;23:29–44.
21. Frank JW, Lovejoy TI, Becker WC, et al. Patient outcomes in dose reduction or discontinuation of long-term opioid therapy: a systematic review. Ann Intern Med 2017;167:181–191.
22. Agnoli A, Xing G, Tancredi DJ, et al. Association of dose tapering with overdose or mental health crisis among patients prescribed long-term opioids. JAMA 2021;326:411–419.
24. Park TW, Saitz R, Ganoczy D, et al. Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study. BMJ 2015;350:h2698.
25. Krawczyk N, Mojtabai R, Stuart EA, et al. Opioid agonist treatment and fatal overdose risk in a state-wide US population receiving opioid use disorder services. Addiction 2020;115:1683–1694.